This browser is not actively supported anymore. For the best passle experience, we strongly recommend you upgrade your browser.

Jenny Leahy

Partner, Freshfields Bruckhaus Deringer

London, United Kingdom

https://www.freshfields.com/en-gb/contacts/find-a-lawyer/l/leahy-jenny/

Jenny.LEAHY@freshfields.com

About me

Jenny’s practice covers contentious and non-contentious EU and UK competition law matters with experience of engaging with the European Commission, the UK Competition and Markets Authority and other competition law enforcement agencies around the world.

She has particular experience of advising clients in the financial services sector. Highlights include advising on high profile merger control transactions, including public takeovers. Based in London, she has also spent time on secondment in our Washington DC office and chairs the Freshfields associate women’s network.

Jenny is fluent in Dutch and English.

Safe harbours for R&D collaboration agreements: Quick guide to the updated EU and UK rules

Jul 05, 2023

Safe harbours for R&D collaboration agreements: Quick guide to the updated EU and UK rules

By Jenny Leahy Kirsty Brown Helen Panteli

The European Commission’s (EC) new R&D block exemption regulation entered into force on 1 July 2023, introducing updated rules for...

Life Sciences Licensing and Collaboration Deals: Antitrust Traps for the Unwary

Apr 21, 2022

Life Sciences Licensing and Collaboration Deals: Antitrust Traps for the Unwary

By Jenny Leahy Adam Golden Rikki Haria +3 more...

With an uptick in antitrust enforcement action across the US, UK, EU and China (among other jurisdictions), companies in the life...

UK National Security and Investment Act: key takeaways for the life sciences industry

Mar 04, 2022

UK National Security and Investment Act: key takeaways for the life sciences industry

By Mary Wilks Jenny Leahy Kirsty Brown +2 more...

The UK’s National Security and Investment Act (the NSI Act), which came into force on 4 January 2022, introduced a new investment...

Life sciences – what to expect in 2022

Jan 24, 2022

Life sciences – what to expect in 2022

By Harriet Hanks Jennifer Bethlehem Adam Golden +3 more...

Innovation and transformation are the watchwords for life sciences in 2022. Digitization and personalization trends are set to continue...

Getting deals through in 2022: new opportunities and risks for companies navigating a complex regulatory environment

Jan 13, 2022

Getting deals through in 2022: new opportunities and risks for companies navigating a complex regulatory environment

By Jenny Leahy Bertrand Guerin Megan Yeates

Companies can expect tough, complex, and unpredictable merger control processes in 2022, as authorities are under pressure to tackle...

Momentum continues to build as Dutch and UK competition authorities publish new sustainability guidance ahead of EC conference

Feb 01, 2021

Momentum continues to build as Dutch and UK competition authorities publish new sustainability guidance ahead of EC conference

By Jenny Leahy Thomas McGrath

Competition authorities in the Netherlands and the UK have staked out their positions in what continues to be one of the hottest topics...

The UK shuts 'the back door' to hostile foreign investment: the new UK national security regime

Nov 12, 2020

The UK shuts 'the back door' to hostile foreign investment: the new UK national security regime

By Michele Davis Sarah Jensen Megan Yeates +1 more...

On 11 November 2020, the UK Government published its long-awaited National Security and Investment Bill (the Bill) in a significant...

The politics of global M&A: navigating foreign investment controls

Jun 23, 2020

The politics of global M&A: navigating foreign investment controls

By Jenny Leahy

The COVID-19 crisis has accelerated global trends towards more expansive reviews of foreign direct investment (FDI). The first half of...

Load more

Worldwide

Our regional experience

Europe

Americas

Asia-Pacific

Middle East

Africa

International language sites